Xencor (XNCR) Cash from Operations (2013 - 2026)
Xencor (XNCR) posted quarterly Cash from Operations of 67628000.0 for Q1 2026, down 316.94% year-over-year from 31173302.26 in Q1 2025, and down 30.78% quarter-over-quarter from 51711000.0 in Q4 2025.
Xencor (XNCR) Cash from Operations (2013 - 2026) Analysis & Trends
Xencor (XNCR) has reported Cash from Operations for 14 consecutive years, with 67628000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash from Operations fell 316.94% year-over-year to 67628000.0; the TTM figure through Mar 2026 stood at 186525000.0 (down 15.46% YoY), while the FY2025 annual figure was 135117000.0, up 33.17% from the prior year.
- Cash from Operations eased to 67628000.0 in Q1 2026 per XNCR's latest filing, from 51711000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 44269000.0 in Q2 2022 and bottomed at 67628000.0 in Q1 2026.
- Historically, Cash from Operations has averaged 26963176.47 across 5 years, with a median of 30614000.0 in 2023.
- Annual changes were most pronounced in 2022 — Cash from Operations jumped 558.56% — and 2023, when it plunged 2235.7%.
- Xencor's Cash from Operations stood at 24431000.0 in 2022, then soared by 174.37% to 18169000.0 in 2023, then plunged by 374.3% to 49837000.0 in 2024, then decreased by 3.76% to 51711000.0 in 2025, then slumped by 30.78% to 67628000.0 in 2026.
- Business Quant data shows XNCR's Cash from Operations at 67628000.0 in Q1 2026, 51711000.0 in Q4 2025, and 30817000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -387.32 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 462.82 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -1.76 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 728.46 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 326.72 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -88.83 Mn |
| 10 | Xencor | 1.73 Bn | 1.36 Bn | - | -55.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -55.66 Mn |
| Jun 30, 2026 | -55.66 Mn |
| Mar 31, 2026 | -67.63 Mn |
| Mar 31, 2026 | -67.63 Mn |
| Dec 31, 2025 | -51.71 Mn |
| Dec 31, 2025 | -51.71 Mn |
| Sep 30, 2025 | -30.82 Mn |
| Sep 30, 2025 | -30.82 Mn |
| Jun 30, 2025 | -36.37 Mn |
| Jun 30, 2025 | -36.37 Mn |
| Mar 31, 2025 | -16.22 Mn |
| Mar 31, 2025 | -16.22 Mn |
| Dec 31, 2024 | -49.84 Mn |
| Dec 31, 2024 | -49.84 Mn |
| Sep 30, 2024 | -28.14 Mn |
| Sep 30, 2024 | -28.14 Mn |
| Jun 30, 2024 | -67.35 Mn |
| Jun 30, 2024 | -67.35 Mn |
| Mar 31, 2024 | -56.86 Mn |
| Mar 31, 2024 | -56.86 Mn |